• Home

  • HEALTH CARE

  • HEALTHY LIFESTYLE

  • HYGIENE

  • COSMETICS

  • FOR HIM

  • PREGNANCY AND MOTHERHOOD

  • CHILD

  • Hepametion lyophilisate for solution for injection, 400mg 5 vials, complete with solvent 5ml x 5 ampoules — Made in Ukraine — Free Delivery


    Brand: Kyivmedpreparat
    Product Code: Hepametion
    Availability: In Stock
    $38.05
    Add to Cart

    Product description

    S-adenosyl-L-methionine (ademetionine) is a natural amino acid that is present in almost all tissues and fluids of the body. Ademethionine mainly acts as a coenzyme and methyl group donor in transmethylation reactions, which is a necessary metabolic process in humans and animals. The transfer of methyl groups (transmethylation) is also a necessary metabolic process during the construction of a double phospholipid layer in cell membranes and promotes membrane fluidity.
    Ademetionine is able to penetrate the blood-brain barrier. The transmethylation process involving ademetionine is key in the formation of central nervous system neurotransmitters, including catecholamines (dopamine, norepinephrine, adrenaline), serotonin, melatonin, and histamine.
    Ademetionine is also a precursor in the formation of physiological sulfonated compounds (cysteine, taurine, glutathione, coenzyme A, etc.) in transsulfurization reactions. Glutathione, a powerful antioxidant in the liver, plays an important role in liver detoxification. Ademetionine increases the level of hepatic glutathione in patients with liver damage of both alcoholic and non-alcoholic genesis. Folic acid (folates) and vitamin B 12 are essential contributors to the metabolism and recovery of ademetionine.

    Indications for use

    Intrahepatic cholestasis in adults, including patients with chronic hepatitis of various etiologies and liver cirrhosis.
    Intrahepatic cholestasis in pregnant women.
    Depressive syndromes.

    Contraindications

    Genetic defects affecting the methionine cycle and / or causing homocystinuria and / or hyperhomocysteinemia (for example, deficiency of cystathionine beta synthase, defect in vitamin B 12 metabolism).
    Hypersensitivity to any component of the preparation.
    Method of administration and dosage
    Treatment can begin with parenteral administration of the preparation followed by the use of the preparation in the form of tablets or immediately after the use of tablets. The daily dose of tablets can be divided into 2-3 doses. It is necessary to prepare a solution for injection immediately before use.
    Initial therapy
    Intravenous or intramuscular: the recommended dose is 5–12 mg / kg of body weight per day. The usual starting dose is 400 mg / day, the total daily dose should not exceed 800 mg. The duration of initial parenteral therapy is 15–20 days in the treatment of depressive syndromes and 2 weeks in the treatment of liver diseases.
    Orally (inside): for oral administration, the ademetionine preparation should be used in the form of tablets. The recommended dose is 10-25 mg / kg of body weight per day. The initial dose is 800 mg / day (2 tablets), the total daily dose should not exceed 1600 mg (4 tablets).
    Supportive therapy
    Administered orally, 2–4 tablets per day (800–1600 mg / day).
    The duration of therapy depends on the severity of the course of the disease and is determined by the doctor individually.
    For intramuscular or intravenous use, dissolve the lyophilized powder in the special supplied solvent immediately before use. For administration, the required dose of ademetionine must be further diluted in 250 ml of saline or 5% glucose (glucose) solution and infused slowly over 1–2 hours. Discard the unused portion of the solution.
    Ademetionine should not be mixed with alkaline solutions or solutions containing calcium ions. If the lyophilized powder has a color other than white to yellowish (due to cracks in the vial or due to the influence of elevated temperature), you should refrain from using it.

    Overdose

    Cases of ademetionine overdose have been reported rarely. In case of overdose, doctors should contact local poison control centers. Monitoring of the patient is recommended and, if necessary, the use of symptomatic treatment.

    Special instructions

    Use during pregnancy or lactation
    In the course of clinical studies in women who were treated with ademetionine in the third trimester of pregnancy, no adverse reactions were observed. Ademetionine in the I and II trimester of pregnancy should be used only after a doctor's careful assessment of the benefit to the pregnant / risk to the fetus ratio.
    During breastfeeding, ademetionine can be used only when the potential benefit from its use outweighs the potential risk to the infant.
    Children
    The safety and efficacy of using ademetionine in children have not been established.
    The ability to influence the reaction rate when driving or driving other mechanisms
    Dizziness may occur in some patients during ademetionine therapy. In such cases, one should refrain from driving vehicles or working with other mechanisms until the symptoms disappear completely, which may affect the reaction rate during these activities.

    Composition

    1 bottle with lyophilisate contains:
    active substance: S-adenosyl-L-methionine 1,4-butanedisulfonate 760 mg in terms of ademetionine cation - 400 mg;
    1 ampoule with solvent contains: L-lysine, sodium hydroxide, water for injection.

    Storage conditions

    Store in its original packaging at a temperature not exceeding 25 ° C. Keep out of the reach of children.

    Shelf life:

    Lyophilisate - 3 years.
    Solvent - 3 years.
    The shelf life of the final product is determined in relation to the component (lyophilisate or solvent), the expiration date of which ends earlier.

    Incompatibility

    Ademetionine (solution for injection) should not be mixed with alkaline solutions or solutions containing calcium ions.

    There are no reviews for this product.